Abstract
Objective: To investigate in a double-blind placebo-controlled, parallel group study, the effects of a nutrient supplement, containing, among other ingredients, the omega-3 fatty acids eicosapentaenoic acid (1.4 g EPA), docosahexaenoic acid (0.211 g DHA), omega-6 fatty acid gamma-linolenic acid (0.5 g GLA) and micronutrients in patients with active rheumatoid arthritis (RA).
Design, subjects and intervention: RA patients were randomized to receive either daily liquid nutrient supplementation or placebo for 4 months. The primary end point was the change in tender joint count at 2 and 4 months. Other clinical variables included swollen joint count, visual analogue scales for pain and disease activity, grip strength, functionality score and morning stiffness. Biochemical parameters included plasma concentrations of PUFA and vitamins C and E.
Setting: Outpatient university clinic.
Results: In all, 66 patients enrolled, 55 completed the study. No significant change from baseline in tender joint count or any of the other clinical parameters was detected in either group. Patients receiving nutrient supplementation, but not those receiving placebo, had significant increases in plasma concentrations of vitamin E (P=0.015), and EPA, DHA and docosapentaenoic acid concomitant with decreases of arachidonic acid (P=0.01). Intergroup differences for PUFA and vitamin E were significantly different (P=0.01 and 0.03, respectively).
Conclusions: This double-blind, placebo-controlled study in RA patients did not show superior clinical benefit of daily nutrient supplementation with EPA, GLA and micronutrients at the doses tested as compared to placebo. The study adds information regarding doses of omega-3 fatty acids, below which anti-inflammatory effects in RA are not seen.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Polyunsaturated fatty acids: any role in rheumatoid arthritis?
Lipids in Health and Disease Open Access 10 October 2017
-
Dietary intake and risk of rheumatoid arthritis—a cross section multicenter study
Clinical Rheumatology Open Access 23 August 2016
-
Dietary supplementation with arachidonic acid increases arachidonic acid content in paw, but does not affect arthritis severity or prostaglandin E2 content in rat adjuvant-induced arthritis model
Lipids in Health and Disease Open Access 16 January 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Belch JJ & Hill A (2000): Evening primrose oil and borage oil in rheumatologic conditions. Am. J. Clin. Nutr. 71, 352S–356S.
Bligh EG & Dyer WT (1959): A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911–920.
Burkhardt H, Schwingel M, Menninger H, Macartney HW & Tschesche H (1986): Oxygen radicals as effectors of cartilage destruction. Arthritis Rheum. 29, 379–387.
Calder PC & Kew S (2002): The immune system: a target for functional foods? Br. J. Nutr. 88(Suppl 2), 5165–5177.
Chilton FH, Patel M, Fonteh AN, Hubbard WC & Triggiani M (1993): Dietary n-3 fatty acid effects on neutrophil lipid composition and mediator production. Influence of duration and dosage. J. Clin. Invest. 91, 115–122.
Cleland LG, James MJ, Neumann MA, D'Angelo M & Gibson RA (1992): Linoleate inhibits EPA incorporation from dietary fish-oil supplements in human subjects. Am. J. Clin. Nutr. 55, 395–399.
Cleland LG, James MJ & Proudman SM (2003): The role of fish oils in the treatment of rheumatoid arthritis. Drugs 63, 845–853.
Darlington LG & Stone TW (2001): Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. Br. J. Nutr. 85, 251–269.
del Rincon ID, Williams K, Stern MP, Freeman GL & Escalante A (2001): High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 44, 2737–2745.
de Vries JHM, Jansen A, Kromhout D, van de Bovenkamp P, van Staveren WA, Mensink RP & Katan MB (1997): The fatty acid and sterol content of food composites of middle-aged men in seven countries. J. Food Compos. Anal. 10, 115–141.
Edmonds SE, Winyard PG, Guo R, Kidd B, Merry P, Langrish-Smith A, Hansen C, Ramm S & Blake DR (1997): Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial. Ann. Rheum. Dis. 56, 649–650.
Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R, Paulus H, Tugwell P, Weinblatt M, Widmark R, Williams HJ & Wolfe F (1993): The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum. 36, 729–740.
Geusens P, Wouters C, Nijs J, Jiang Y & Dequeker J (1994): Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study. Arthritis Rheum. 37, 824–829.
Johnson MM, Swan DD, Surette ME, Stegner J, Chilton T, Fonteh AN & Chilton FH (1997): Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J. Nutr. 127, 1435–1444.
Jikimoto T, Nishikubo Y, Koshiba M, Kanagawa S, Morinobu S, Morinobu A, Saura R, Mizuno K, Kondo S, Toyokuni S, Nakamura H, Yodoi J & Kumagai S (2002): Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol. Immunol. 38, 765–772.
Kaluzny MA, Duncan LA, Merritt MV & Epps DE (1985): Rapid separation of lipid classes in high yield and purity using bonded phase columns. J. Lipid Res. 26, 135–140.
Kheir-Eldin AA, Hamdy MA, Motawi TK, Shaheen AA & Abd el Gawad HM (1992): Biochemical changes in arthritic rats under the influence of vitamin E. Agents Actions 36, 300–305.
Kremer JM (2000): n-3 fatty acid supplements in rheumatoid arthritis. Am. J. Clin. Nutr. 71, 349S–351S.
Kremer JM, Lawrence DA, Jubiz W, DiGiacomo R, Rynes R, Bartholomew LE & Sherman M (1990): Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum. 33, 810–820.
Kris-Etherton PM, Harris WS & Appel LJ (2002): Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747–2757.
Laidlaw M & Holub BJ (2003): Effects of supplementation with fish oil-derived n-3 fatty acids and γ-linolenic acid on circulating plasma lipids and fatty acid profiles in women. Am. J. Clin. Nutr. 77, 37–42.
Liau LS, Lee BL, New AL & Ong CN (1993): Determination of plasma ascorbic acid by high-performance liquid chromatography with ultraviolet and electrochemical detection. J. Chromatogr. 612, 63–70.
Lunec J, Halloran SP, White AG & Dormandy TL (1981): Free radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J. Rheumatol. 8, 233–244.
Morrison WR & Smith LM (1964): Preparation of fatty acids methyl esters and dimethylacetals from lipids with boron fluoride methanol. J. Lipid Res. 5, 600–607.
Peretz A, Siderova V & Neve J (2001): Selenium supplementation in rheumatoid arthritis investigated in a double blind, placebo-controlled trial. Scand. J. Rheumatol. 30, 208–212.
Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB & van Riel PL (1995): Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 41, 44–48.
Rosenstein ED & Caldwell JR (1999): Trace elements in the treatment of rheumatoid arthritis. Rheum. Dis. Clin. North Am. 25, 929–935.
Sakai A, Hirano T, Okazaki R, Okimoto N, Tanaka K & Nakamura T (1999): Large-dose ascorbic acid administration suppresses the development of arthritis in adjuvant-infected rats. Arch. Orthop. Trauma Surg. 119, 121–126.
Simopoulos AP (2002): The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed. Pharmacother. 56, 365–379.
Sköldstam L, Börjesson O, Kjällman A, Seiving B & Åkesson B (1992): Effect of six months of fish oil supplementation in stable rheumatoid arthritis. A double-blind, controlled study. Scand. J. Rheumatol. 21, 178–185.
Stone SJ, Doube A, Dudson D & Wallace J (1997): Inadequate calcium, folic acid, vitamin E, zinc, and selenium intake in rheumatoid arthritis patients: results of a dietary survey. Semin. Arthritis Rheum. 27, 180–185.
Stump DD, Roth Jr EF & Gilbert HS (1984): Simultaneous determination by high-performance liquid chromatography of tocopherol isomers, alpha-tocopherol quinone, and cholesterol in red blood cells and plasma. J. Chromatogr. 306, 377–382.
Tarp U, Overvad K, Thorling EB, Graudal H & Hansen JC (1985): Selenium treatment in rheumatoid arthritis. Scand. J. Rheumatol. 14, 364–368.
Taysi S, Polat F, Gul M, Sari RA & Bakan E (2002): Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol. Int. 21, 200–204.
Tsuji F, Miyake Y, Aono H, Kawashima Y & Mita S (1999): Effects of bucillamine and N-acetyl-L-cysteine on cytokine production and collagen-induced arthritis (CIA). Clin. Exp. Immunol. 115, 26–31.
Venkatraman JT & Chu WC (1999): Effects of dietary omega-3 and omega-6 lipids and vitamin E on serum cytokines, lipid mediators and anti-DNA antibodies in a mouse model for rheumatoid arthritis. J. Am. Coll. Nutr. 18, 602–613.
Zurier RB, Rossetti RG, Jacobson EW, DeMarco DM, Liu NY, Temming JE, White BM & Laposata M (1996): Gamma-linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial. Arthritis Rheum. 39, 1808–1817.
Acknowledgements
We thank Dr M Froelich (LUMC) and Dr J van den Berg (Numico Research) for laboratory analyses. This study was supported by a research grant from Senter/Dutch Ministry of Economic Affairs (BTS-99036).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Remans, P., Sont, J., Wagenaar, L. et al. Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects. Eur J Clin Nutr 58, 839–845 (2004). https://doi.org/10.1038/sj.ejcn.1601883
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1601883
Keywords
This article is cited by
-
Microwave-assisted extraction of hempseed oil: studying and comparing of fatty acid composition, antioxidant activity, physiochemical and thermal properties with Soxhlet extraction
Journal of Food Science and Technology (2019)
-
Polyunsaturated fatty acids: any role in rheumatoid arthritis?
Lipids in Health and Disease (2017)
-
Dietary intake and risk of rheumatoid arthritis—a cross section multicenter study
Clinical Rheumatology (2016)
-
Dietary supplementation with arachidonic acid increases arachidonic acid content in paw, but does not affect arthritis severity or prostaglandin E2 content in rat adjuvant-induced arthritis model
Lipids in Health and Disease (2015)
-
An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases
Journal of Physiology and Biochemistry (2015)